{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:08:15Z","timestamp":1791248895415,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.tiv.2013.06.024","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T17:31:45Z","timestamp":1373391105000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies"],"prefix":"10.1016","volume":"28","author":[{"given":"Daniel","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fozia","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2013.06.024_b0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2013.06.024_b0010","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells","author":"Antherieu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2013.06.024_b0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","article-title":"Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10","volume":"37","author":"Argikar","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2013.06.024_b0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF01962701","article-title":"Metabolism of valproate to hepatotoxic intermediates","volume":"14","author":"Baillie","year":"1992","journal-title":"Pharm. Weekblad Sci."},{"key":"10.1016\/j.tiv.2013.06.024_b0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2005.11.018","article-title":"Aflatoxin B1-induced DNA damage and its repair","volume":"241","author":"Bedard","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2013.06.024_b0030","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.tiv.2006.01.013","article-title":"Investigation of the hepatotoxicity profile of chemical entities using liverbeads and WIF-B9 in vitro models","volume":"20","author":"Biagini","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2013.06.024_b0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.tiv.2013.01.010","article-title":"In vitro biokinetics of chlorpromazine and the influence of different dose metrics on effect concentrations for cytotoxicity in Balb\/c 3T3, Caco-2 and HepaRG cell cultures","volume":"27","author":"Broeders","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2013.06.024_b0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510280122","article-title":"The polarized hepatic human\/rat hybrid WIF 12-1 and WIF-B cells communicate efficiently in vitro via connexin 32-constituted gap junctions","volume":"28","author":"Chaumontet","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2013.06.024_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2012.06.048","article-title":"An approach to the toxicity and toxicokinetics of aflatoxin B1 and ochratoxin A after simultaneous oral administration to fasted F344 rats","author":"Corcuera","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tiv.2013.06.024_b0050","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1124\/dmd.110.037721","article-title":"Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor","volume":"39","author":"Darnell","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2013.06.024_b0055","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.112.195834","article-title":"In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and in a dynamic three-dimensional bioreactor system","author":"Darnell","year":"2012","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.tiv.2013.06.024_b0060","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/biot.201100290","article-title":"Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues","volume":"6","author":"Drewitz","year":"2011","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.tiv.2013.06.024_b0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03259935","article-title":"Valproate-associated hepatotoxicity and its biochemical mechanisms","volume":"3","author":"Eadie","year":"1988","journal-title":"Med. Toxicol. Adverse Drug Exp."},{"key":"10.1016\/j.tiv.2013.06.024_b0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/toxsci\/kfs122","article-title":"Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line","volume":"127","author":"Fey","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2013.06.024_b0075","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/01.TP.0000083319.36931.32","article-title":"Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study","volume":"76","author":"Gerlach","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.tiv.2013.06.024_b0080","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/hep.22880","article-title":"Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis","volume":"49","author":"Godoy","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2013.06.024_b0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.etp.2010.10.008","article-title":"Cytotoxicity effects of amiodarone on cultured cells","volume":"64","author":"Golli-Bennour","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2013.06.024_b0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1389200033489424","article-title":"Human hepatocytes as a tool for studying toxicity and drug metabolism","volume":"4","author":"Gomez-Lechon","year":"2003","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tiv.2013.06.024_b0095","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2013.06.024_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Guengerich","year":"2011","journal-title":"Drug Metab. Pharm."},{"issue":"Suppl. 2","key":"10.1016\/j.tiv.2013.06.024_b0105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1289\/ehp.98106511","article-title":"Liver cell models in in vitro toxicology","volume":"106","author":"Guillouzo","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2013.06.024_b0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2013.06.024_b0115","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kft021","article-title":"3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies","author":"Gunness","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2013.06.024_b0120","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1242\/jcs.02403","article-title":"Three-dimensional polarization sensitizes hepatocytes to Fas\/CD95 apoptotic signalling","volume":"118","author":"Haouzi","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tiv.2013.06.024_b0335","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","article-title":"Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment","volume":"95","author":"Hobbs","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2013.06.024_b0130","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.biocel.2011.06.011","article-title":"The HepaRG cell line is suitable for bioartificial liver application","volume":"43","author":"Hoekstra","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tiv.2013.06.024_b0135","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/mp800047v","article-title":"3-D tumor model for in vitro evaluation of anticancer drugs","volume":"5","author":"Horning","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tiv.2013.06.024_b0140","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2013.06.024_b0145","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1248\/bpb.28.1934","article-title":"Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population","volume":"28","author":"Kashima","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tiv.2013.06.024_b0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tibtech.2004.02.002","article-title":"Microscale tissue engineering using gravity-enforced cell assembly","volume":"22","author":"Kelm","year":"2004","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tiv.2013.06.024_b0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bit.10655","article-title":"Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types","volume":"83","author":"Kelm","year":"2003","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tiv.2013.06.024_b0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/wsbm.1167","article-title":"Isotope labeling experiments in metabolomics and fluxomics","volume":"4","author":"Klein","year":"2012","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.tiv.2013.06.024_b0165","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1006\/bbrc.1996.0454","article-title":"Modulation of the expression of liver-specific functions in novel human hepatocyte lines cultured in a collagen gel sandwich configuration","volume":"220","author":"Kono","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tiv.2013.06.024_b0170","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/tx200479k","article-title":"Quantifying processes determining the free concentration of phenanthrene in Basal cytotoxicity assays","volume":"25","author":"Kramer","year":"2012","journal-title":"Chem. Res. Toxicol."},{"issue":"Suppl. 2","key":"10.1016\/j.tiv.2013.06.024_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(97)80492-8","article-title":"Genetic predisposition to drug-induced hepatotoxicity","volume":"26","author":"Larrey","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2013.06.024_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"Latini","year":"1984","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tiv.2013.06.024_b0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejps.2006.01.004","article-title":"Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line","volume":"28","author":"Le Vee","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2013.06.024_b0190","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfs232","article-title":"3D HepaRG model as an attractive tool for toxicity testing","author":"Leite","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2013.06.024_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2012.05.003","volume":"199","author":"Li","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2013.06.024_b0200","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.tiv.2011.05.018","article-title":"Lactate is an ideal non-invasive marker for evaluating temporal alterations in cell stress and toxicity in repeat dose testing regimes","volume":"25","author":"Limonciel","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2013.06.024_b0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","article-title":"HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro","volume":"63","author":"Lubberstedt","year":"2011","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tiv.2013.06.024_b0210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/026119291103900210","article-title":"Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines \u2013 a report on the Vitrocellomics EU-project","volume":"39","author":"Mandenius","year":"2011","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.tiv.2013.06.024_b0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jat.1663","article-title":"Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review","volume":"31","author":"Mandenius","year":"2011","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tiv.2013.06.024_b0220","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.24132","article-title":"HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity","volume":"53","author":"McGill","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2013.06.024_b0225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(94)00054-7","article-title":"Cellular interactions and metabolism of aflatoxin: an update","volume":"65","author":"McLean","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2013.06.024_b0230","first-page":"002","article-title":"Organotypic cultures of HepG2 cells for in vitro toxicity studies","volume":"2","author":"Mueller","year":"2011","journal-title":"J. Bioeng. Biomed. Sci. S"},{"key":"10.1016\/j.tiv.2013.06.024_b0240","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1002\/term.418","article-title":"In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor","volume":"5","author":"Mueller","year":"2011","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.tiv.2013.06.024_b0235","article-title":"Real-time in situ viability assessment in a 3D bioreactor with liver cells using resazurin assay","author":"Mueller","year":"2012","journal-title":"Cytotechnology"},{"key":"10.1016\/j.tiv.2013.06.024_b0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00335-002-2179-2","article-title":"Differential gene expression analysis during porcine hepatocyte spheroid formation","volume":"13","author":"Narayanan","year":"2002","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.tiv.2013.06.024_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/bit.24586","article-title":"Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver","author":"Nibourg","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tiv.2013.06.024_b0255","doi-asserted-by":"crossref","first-page":"e38778","DOI":"10.1371\/journal.pone.0038778","article-title":"Liver progenitor cell line HepaRG Differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure","volume":"7","author":"Nibourg","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2013.06.024_b0260","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.taap.2009.07.005","article-title":"Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2","volume":"240","author":"Niklas","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2013.06.024_b0265","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0090-9556(24)15077-5","article-title":"A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor","volume":"28","author":"Ohyama","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2013.06.024_b0270","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2013.06.024_b0275","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0163-7258(95)02013-6","article-title":"The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity","volume":"68","author":"Park","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2013.06.024_b0280","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gut.25.6.673","article-title":"Hepatotoxicity to sodium valproate: a review","volume":"25","author":"Powell-Jackson","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.tiv.2013.06.024_b0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/13813455.2012.683442","article-title":"The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism","volume":"118","author":"Samanez","year":"2012","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.tiv.2013.06.024_b0290","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1034\/j.1399-3089.2003.00062.x","article-title":"Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells","volume":"10","author":"Sauer","year":"2003","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.tiv.2013.06.024_b0295","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.2174\/138161205774414510","article-title":"Why drugs fail \u2013 a study on side effects in new chemical entities","volume":"11","author":"Schuster","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tiv.2013.06.024_b0300","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0168-8278(01)00189-1","article-title":"Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria","volume":"35","author":"Spaniol","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2013.06.024_b0305","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3727\/000000003108747163","article-title":"Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver","volume":"12","author":"van de Kerkhove","year":"2003","journal-title":"Cell Transplant."},{"key":"10.1016\/j.tiv.2013.06.024_b0315","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1124\/jpet.106.108993","article-title":"Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives","volume":"319","author":"Waldhauser","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2013.06.024_b0310","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjp.2008.287","article-title":"Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues","volume":"155","author":"Waldhauser","year":"2008","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.tiv.2013.06.024_b0320","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cbi.2009.05.014","article-title":"Metabolic activation of the phenothiazine antipsychotics chlorpromazine and thioridazine to electrophilic iminoquinone species in human liver microsomes and recombinant P450s","volume":"181","author":"Wen","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tiv.2013.06.024_b0325","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/hup.869","article-title":"Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder","volume":"22","author":"Winter","year":"2007","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.tiv.2013.06.024_b0330","first-page":"3752","article-title":"Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size","volume":"55","author":"Yuan","year":"1995","journal-title":"Cancer Res."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313001768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233313001768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T13:01:21Z","timestamp":1746018081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233313001768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0887233313001768"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2013.06.024","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2013.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}